Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
Clinical trial NCT00520975 · TERMINATED
Trial details
- NCT number
- NCT00520975
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.